These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10475107)

  • 1. Zidovudine-induced experimental myopathy: dual mechanism of mitochondrial damage.
    Masini A; Scotti C; Calligaro A; Cazzalini O; Stivala LA; Bianchi L; Giovannini F; Ceccarelli D; Muscatello U; Tomasi A; Vannini V
    J Neurol Sci; 1999 Jul; 166(2):131-40. PubMed ID: 10475107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits.
    Yerroum M; Pham-Dang C; Authier FJ; Monnet I; Gherardi R; Chariot P
    Acta Neuropathol; 2000 Jul; 100(1):82-6. PubMed ID: 10912924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage.
    Dalakas MC; Leon-Monzon ME; Bernardini I; Gahl WA; Jay CA
    Ann Neurol; 1994 Apr; 35(4):482-7. PubMed ID: 8154877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.
    Scruggs ER; Dirks Naylor AJ
    Pharmacology; 2008; 82(2):83-8. PubMed ID: 18504416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early effects of AZT on mitochondrial functions in the absence of mitochondrial DNA depletion in rat myotubes.
    Cazzalini O; Lazzè MC; Iamele L; Stivala LA; Bianchi L; Vaghi P; Cornaglia A; Calligaro A; Curti D; Alessandrini A; Prosperi E; Vannini V
    Biochem Pharmacol; 2001 Oct; 62(7):893-902. PubMed ID: 11543724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, histological and molecular reversibility of zidovudine myopathy.
    Masanés F; Barrientos A; Cebrián M; Pedrol E; Miró O; Casademont J; Grau JM
    J Neurol Sci; 1998 Aug; 159(2):226-8. PubMed ID: 9741412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of reactive oxygen species and poly-ADP-ribose polymerase in the development of AZT-induced cardiomyopathy in rat.
    Szabados E; Fischer GM; Toth K; Csete B; Nemeti B; Trombitas K; Habon T; Endrei D; Sumegi B
    Free Radic Biol Med; 1999 Feb; 26(3-4):309-17. PubMed ID: 9895221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins.
    de la Asunción JG; del Olmo ML; Sastre J; Millán A; Pellín A; Pallardó FV; Viña J
    J Clin Invest; 1998 Jul; 102(1):4-9. PubMed ID: 9649550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies.
    Pezeshkpour G; Illa I; Dalakas MC
    Hum Pathol; 1991 Dec; 22(12):1281-8. PubMed ID: 1748434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessment of mitochondrial toxicity induced by zidovudine and adefovir dipivoxil in rats].
    Zhu B; Zhu ZN; Wang JZ; Huang SM; Feng XM; Li AY; Yang DL; Wang BJ
    Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):794-7. PubMed ID: 23207344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zidovudine (AZT) causes an oxidation of mitochondrial DNA in mouse liver.
    de la Asunción JG; del Olmo ML; Sastre J; Pallardó FV; Viña J
    Hepatology; 1999 Mar; 29(3):985-7. PubMed ID: 10051507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of L-carnitine on the zidovudine-induced destruction of human myotubes. Part I: L-carnitine prevents the myotoxicity of AZT in vitro.
    Semino-Mora MC; Leon-Monzon ME; Dalakas MC
    Lab Invest; 1994 Jul; 71(1):102-12. PubMed ID: 7518879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of short-term zidovudine exposure on mitochondrial DNA content and succinate dehydrogenase activity of rat skeletal muscle cells.
    Kiyomoto BH; Tengan CH; Godinho RO
    J Neurol Sci; 2008 May; 268(1-2):33-9. PubMed ID: 18045616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells.
    Benbrik E; Chariot P; Bonavaud S; Ammi-Saïd M; Frisdal E; Rey C; Gherardi R; Barlovatz-Meimon G
    J Neurol Sci; 1997 Jul; 149(1):19-25. PubMed ID: 9168161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal patas monkeys sustain mitochondrial toxicity as a result of in utero zidovudine exposure.
    Gerschenson M; Poirier MC
    Ann N Y Acad Sci; 2000 Nov; 918():269-81. PubMed ID: 11131713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria.
    Lewis W; Gonzalez B; Chomyn A; Papoian T
    J Clin Invest; 1992 Apr; 89(4):1354-60. PubMed ID: 1556193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AZT myopathy and HIV-1 polymyositis: one disease or two?
    Walsh K; Kaye K; Demaerschalk B; Stewart S; Crukley J; Hammond R
    Can J Neurol Sci; 2002 Nov; 29(4):390-3. PubMed ID: 12463497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AZT-induced mitochondrial myopathy.
    Tomelleri G; Tonin P; Spadaro M; Tilia G; Orrico D; Barelli A; Bonetti B; Monaco S; Salviati A; Morocutti C
    Ital J Neurol Sci; 1992 Dec; 13(9):723-8. PubMed ID: 1336487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3'-azido-3'-deoxythymidine.
    Gerschenson M; Erhart SW; Paik CY; St Claire MC; Nagashima K; Skopets B; Harbaugh SW; Harbaugh JW; Quan W; Poirier MC
    AIDS Res Hum Retroviruses; 2000 May; 16(7):635-44. PubMed ID: 10791874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice.
    Lebrecht D; Deveaud C; Beauvoit B; Bonnet J; Kirschner J; Walker UA
    Arthritis Rheum; 2008 Jan; 58(1):318-26. PubMed ID: 18163507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.